title: Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81.
authors.affiliation: Division of Urology, Sidney Kimmel Center for Prostate and Urologic Cancer, 1275 York Avenue, Box 27, New York, NY 10065, USA. sfshariat@gmail.com
authors.forename: Shahrokh F
authors.initials: SF
authors.lastname: Shariat
authors.forename: Jose A
authors.initials: JA
authors.lastname: Karam
authors.forename: Pierre I
authors.initials: PI
authors.lastname: Karakiewicz